Clinical Trials Directory

Trials / Completed

CompletedNCT01376206

Drug Use Investigation for ALLERMIST

Status
Completed
Phase
Study type
Observational
Enrollment
2,000 (actual)
Sponsor
GlaxoSmithKline · Industry
Sex
All
Age
Healthy volunteers
Not accepted

Summary

To investigate possible problems or questions in safety and efficacy of ALLERMIST Nasal Spray in Japanese subjects with allergic rhinitis under the practical use conditions

Conditions

Interventions

TypeNameDescription
DRUGFluticasoneCollection of safety data

Timeline

Start date
2009-12-01
Primary completion
2010-09-01
Completion
2011-05-01
First posted
2011-06-20
Last updated
2017-05-22

Source: ClinicalTrials.gov record NCT01376206. Inclusion in this directory is not an endorsement.